The effect of crude and pure hCG preparations on bovine TSH (bTSH) binding to its receptor was investigated in an attempt to characterize further the intrinsic thyrotropic activity of hCG. In a TSH radioreceptorassay with bovine thyroid membranes, performed at 4 C without NaCl in the incubation medium, the cross-reactivity of a crude hCG preparation was 90% relative to unlabeled bTSH, whereas that of pure hCG and its subunits was below 0.01%. By Sephadex G-100 chromatography, the substances in crude hCG that displayed TSH binding inhibitory activity at 4 C exhibited great heterogeneity, with an apparent molecular size range of 6,000-70,000 daltons. No specific peaks of TSH binding inhibitory substances were observed in the elution region of hCG, TSH, or molar or chorionic TSH, and most of the inhibitory substances had apparent molecular sizes smaller than any known TSH. When the radioreceptorassay was performed under progressively more physiological conditions by raising the temperature to 37 C and adding NaCl to the incubation buffer, the crossreactivity of crude and pure hCG relative to bTSH fell to 0.003- 0.005% both with bovine and human thyroid membranes. The similar effects of crude and pure hCG under near physiological incubation conditions suggested that the active substance in the crude hCG preparation was indeed hCG, whereas the effect of the other substances in the preparation had been abolished. Under such conditions, no cross-reactivity of hCG subunits was observed, whereas the cross-reactivity of human TSH was 10%, that of human LH was 0.3%, and that of human FSH was 0.1% relative to bTSH. Based on the TSH radioreceptorassay performed under near physiological incubation conditions, resulting in maximal TSH sensitivity and specificity, the thyrotropic activity of 1 IU (gonadotropic activity) of hCG is thus equivalent to 0.05-0.08 juIU bTSH.